Literature DB >> 31210047

Trends in chronic disease incidence rates from the Canadian Chronic Disease Surveillance System.

Naomi C Hamm1, Louise Pelletier2, Joellyn Ellison2, Lana Tennenhouse2, Kim Reimer3, J Michael Paterson4, Rolf Puchtinger5, Sharon Bartholomew2, Karen A M Phillips6, Lisa M Lix1.   

Abstract

INTRODUCTION: The Public Health Agency of Canada's Canadian Chronic Disease Surveillance System (CCDSS) produces population-based estimates of chronic disease prevalence and incidence using administrative health data. Our aim was to assess trends in incidence rates over time, trends are essential to understand changes in population risk and to inform policy development.
METHODS: Incident cases of diagnosed asthma, chronic obstructive pulmonary disease (COPD), diabetes, hypertension, ischemic heart disease (IHD), and stroke were obtained from the CCDSS online infobase for 1999 to 2012. Trends in national and regional incidence estimates were tested using a negative binomial regression model with year as a linear predictor. Subsequently, models with year as a restricted cubic spline were used to test for departures from linearity using the likelihood ratio test. Age and sex were covariates in all models.
RESULTS: Based on the models with year as a linear predictor, national incidence rates were estimated to have decreased over time for all diseases, except diabetes; regional incidence rates for most diseases and regions were also estimated to have decreased. However, likelihood ratio tests revealed statistically significant departures from a linear year effect for many diseases and regions, particularly for hypertension.
CONCLUSION: Chronic disease incidence estimates based on CCDSS data are decreasing over time, but not at a constant rate. Further investigations are needed to assess if this decrease is associated with changes in health status, data quality, or physician practices. As well, population characteristics that may influence changing incidence trends also require exploration.

Entities:  

Keywords:  administrative data; chronic disease surveillance; trend analysis

Mesh:

Year:  2019        PMID: 31210047      PMCID: PMC6699608          DOI: 10.24095/hpcdp.39.6/7.02

Source DB:  PubMed          Journal:  Health Promot Chronic Dis Prev Can        ISSN: 2368-738X            Impact factor:   3.240


  7 in total

1.  Regional variation in multimorbidity prevalence in British Columbia, Canada: a cross-sectional analysis of Canadian Community Health Survey data, 2015/16.

Authors:  C Andrew Basham
Journal:  Health Promot Chronic Dis Prev Can       Date:  2020-08       Impact factor: 3.240

2.  At-a-glance - Twenty years of diabetes surveillance using the Canadian Chronic Disease Surveillance System.

Authors:  Allana G LeBlanc; Yong Jun Gao; Louise McRae; Catherine Pelletier
Journal:  Health Promot Chronic Dis Prev Can       Date:  2019-11       Impact factor: 3.240

Review 3.  Validated methods for identifying individuals with obesity in health care administrative databases: A systematic review.

Authors:  Sékou Samadoulougou; Leanne Idzerda; Roxane Dault; Alexandre Lebel; Anne-Marie Cloutier; Alain Vanasse
Journal:  Obes Sci Pract       Date:  2020-09-04

4.  Cognitive leisure activity and all-cause mortality in older adults: a 4-year community-based cohort.

Authors:  Xin Liu; Ye Ruan; Limei Huang; Yanfei Guo; Shuangyuan Sun; Hao Chen; Junling Gao; Yan Shi; Qianyi Xiao
Journal:  BMC Geriatr       Date:  2021-04-09       Impact factor: 3.921

5.  Control charts for chronic disease surveillance: testing algorithm sensitivity to changes in data coding.

Authors:  Naomi C Hamm; Depeng Jiang; Ruth Ann Marrie; Pourang Irani; Lisa M Lix
Journal:  BMC Public Health       Date:  2022-02-28       Impact factor: 3.295

6.  Neighbourhood characteristics related to mental health service use among adults with diabetes: a population-based cohort study in New Brunswick, Canada.

Authors:  Neeru Gupta; Dan Lawson Crouse; Ismael Foroughi
Journal:  BMC Res Notes       Date:  2022-02-23

7.  Advanced detection strategies for cardiotropic virus infection in a cohort study of heart failure patients.

Authors:  Paul J Hanson; Felicia Liu-Fei; Taylor A Minato; Al Rohet Hossain; Harpreet Rai; Victoria A Chen; Coco Ng; Kjetil Ask; Jeremy A Hirota; Bruce M McManus
Journal:  Lab Invest       Date:  2021-10-04       Impact factor: 5.662

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.